Funder
Gilead
AbbVie
Wako Diagnostics
Merck
Janssen
Bayer
Biotest
Conatus
Genfit
Gilead Sciences
Intercept
Dova
Exact Sciences
Shire
National Cancer Institute
Subject
Gastroenterology,Hepatology
Reference36 articles.
1. Annual report to the nation on the status of cancer, part I: national cancer statistics;Cronin;Cancer,2018
2. Hepatocellular carcinoma confirmation, treatment, and survival in Surveillance, Epidemiology, and End Results registries, 1992–2008;Altekruse;Hepatology,2012
3. Radiofrequency ablation for hepatocellular carcinoma: 10-year outcome and prognostic factors;Shiina;Am J Gastroenterol,2012
4. Recurrence of hepatocellular cancer after resection: patterns, treatments, and prognosis;Tabrizian;Ann Surg,2015
5. Hepatocellular carcinoma responding to superselective transarterial chemoembolization: an issue of nodule dimension?;Golfieri;J Vasc Interv Radiol,2013
Cited by
123 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Multidisciplinary Treatment of Hepatocellular Carcinoma in 2023: Italian practice Treatment Guidelines of the Italian Association for the Study of the Liver (AISF), Italian Association of Medical Oncology (AIOM), Italian Association of Hepato-Bilio-Pancreatic Surgery (AICEP), Italian Association of Hospital Gastroenterologists (AIGO), Italian Association of Radiology and Clinical Oncology (AIRO), Italian Society of Pathological Anatomy and Diagnostic Cytology (SIAPeC-IAP), Italian Society of Surgery (SIC), Italian Society of Gastroenterology (SIGE), Italian Society of Medical and Interventional Radiology (SIRM), Italian Organ Transplant Society (SITO), and Association of Patients with Hepatitis and Liver Disease (EpaC) – Part I – Surgical treatments;Digestive and Liver Disease;2024-02
2. Hepatocellular Carcinoma Surveillance Patterns and Outcomes in Patients With Cirrhosis;Clinical Gastroenterology and Hepatology;2024-02
3. Racial and ethnic disparities in untreated patients with hepatitis C virus‐related hepatocellular carcinoma but not in those with sustained virologic response;Alimentary Pharmacology & Therapeutics;2024-01-03
4. Controversies of Direct-Acting Antivirals in Hepatocellular Carcinoma;Surgical Oncology Clinics of North America;2024-01
5. Proportion of Time Covered by Hepatocellular Carcinoma Surveillance in Patients With Cirrhosis;American Journal of Gastroenterology;2024-01-01